Amedisys Inc (AMED) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amedisys Inc  (NASDAQ: AMED)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Amedisys Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amedisys Inc's ROI in the second quarter of 2025?
Amedisys Inc achieved a return on average invested assets (ROI) of 4.76 % in its second quarter of 2025, which is below Amedisys Inc's average return on investment, which stands at 5.4%.

ROI decreased relative to the period ending Mar 31 2025, due to the decline in net income.

Within the Healthcare sector 158 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 1247 to 1358.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM 4.24 % 4.91 % 3.88 % 2.85 % 0.56 %
Y / Y Net Income Change TTM -10.82 % - - - -
Investment (TTM) in Millions 1,769 1,738 1,670 1,706 1,691
Return On Investment (TTM) 4.76 % 5.02 % 2.27 % 4.94 % 5.56 %
AMED's Overall Ranking # 1358 # 1247 # 1786 # 1082 # 1031
Seq. Investment Change TTM 1.15 % 1.17 % 0.45 % 1.41 % 1.81 %
Seq. Net Income Change TTM -4.12 % 123.75 % -53.86 % -9.91 % -
Net Income (TTM) in Millions 82 85 38 83 92

AMED Company Profile >> Back to AMED Roi Comparisons >> See Annual AMED Return On Investment



Return On Investment AMED's Ranking
Within: No.
Industry # 20
Sector # 159
Overall # 1358

Return On Investment Statistics
High Average Low
22.08 %
5.4 %
-42.55 %
(Dec 31 2018)   (Sep 30 2013)







Financial Statements
Amedisys Inc's II. Quarter Investments $ 1,769 Millions AMED's Balance sheet
Amedisys Inc's II. Quarter Income $ 29 Millions Quarterly AMED's Income Statement
AMED's Income by Division See AMED's Income by Division


AMED Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 1,670 1,640 1,676 1,458 1,050
Y / Y Investment Growth 1.83 % -2.15 % 14.91 % 38.84 % 19.26 %
Net Income in Millions 38 -11 118 210 185
Y / Y Net Income Growth - - -44 % 13.49 % 44.78 %
Annual Return On Investment 2.29 % -0.67 % 7.02 % 14.41 % 17.63 %


Annual Roi Comment
In the fiscal year 2024 ROI improved to 2.29 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMED's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMED's Competitors
Subscribers only: Roi for Amedisys Inc's Suppliers
Subscribers only: Return On Investment for AMED's Customers

Other Ratios
AMED's Roa AMED's Inventory Turnover Ratio AMED's Growth Rates AMED's Dividend Statistics
AMED's Profitability Ratios AMED's Asset Turnover Ratio AMED's Dividend Growth
AMED's Roe AMED's Valuation Ratios AMED's Financial Strength Ratios AMED's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI
Msa Safety Inc  13.01 %
Protalix Biotherapeutics inc   12.75 %
Tg Therapeutics Inc   12.24 %
Caredx Inc   11.95 %
Ufp Technologies Inc   11.93 %
Pacific Health Care Organization Inc  11.75 %
Encompass Health Corporation  11.61 %
Alpha Pro Tech Ltd   11.56 %
Progyny Inc   11.05 %
Cryoport inc   10.99 %
Emergent Biosolutions Inc   10.99 %
Black Diamond Therapeutics Inc   10.94 %
Universal Health Services Inc   10.91 %
Neurocrine Biosciences Inc   10.86 %
Utah Medical Products Inc  10.42 %
Align Technology inc   10.41 %
Biomarin Pharmaceutical Inc  10.19 %
Kewaunee Scientific Corporation  10.15 %
Amgen Inc   10.03 %
Viemed Healthcare Inc   9.86 %
Lemaitre Vascular Inc   9.53 %
Amphastar Pharmaceuticals Inc   9.53 %
Transmedics Group Inc   9.29 %
Penumbra Inc  9.23 %
Ge Healthcare Technologies Inc   9.23 %
Insulet Corporation  8.96 %
Tenet Healthcare Corp  8.65 %
Haemonetics Corporation  8.54 %
Mannkind Corporation  8.49 %
Globus Medical Inc   8.09 %

Date modified: 2026-09-26T06:58:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.